Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $34.9 million versus the consensus estimate of $36.96 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.